Insmed, Inc. (INSM)
107.01
-1.86
(-1.71%)
USD |
NASDAQ |
May 27, 15:01
Insmed Free Cash Flow : -951.64M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals, Inc. | -275.41M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| PTC Therapeutics, Inc. | -516.78M |
| United Therapeutics Corp. | 1.011B |
| Protagonist Therapeutics, Inc. | -117.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -222.74M |
| Cash from Investing (Quarterly) | 265.52M |
| Cash from Financing (Quarterly) | 29.51M |
| Free Cash Flow Per Share (Quarterly) | -1.050 |
| Free Cash Flow to Equity (Quarterly) | -218.67M |
| Free Cash Flow to Firm (Quarterly) | -205.95M |
| Free Cash Flow Yield | -4.28% |